Role of adiponectin gene variants, adipokines and hydrometry-based percent body fat in metabolically healthy and abnormal obesity

Obesity Research and Clinical Practice

Volumn 12, Issue 1, 2018, Pages 49-61

  Chang, Chin Sung ^a,b   Lu, Yan Jia ^a   Chang, Hsiu Hao ^a   Hsu, Shih Han ^a   Kuo, Po Hsiu ^c   Shieh, Chi Chang ^a   Yao, Wei Jen ^a   Hsu, Mei Chi ^a   Young, Kung Chia ^a   Lin, Wen Yuan ^d   Huang, Kuo Chin ^c   Wu, Chih Hsing ^b,e   Tsai, Yau Sheng ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Adipokine; Adiponectin T45G polymorphism; Metabolically abnormal obesity; Metabolically healthy obesity; Percent body fat

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; DEUTERIUM OXIDE; GENOMIC DNA; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; RESISTIN; TRIACYLGLYCEROL;

ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT; BODY WEIGHT MANAGEMENT; CONTROLLED STUDY; DIET RESTRICTION; DILUTION; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GLUCOSE LEVEL; HUMAN; INTENTION TO TREAT ANALYSIS; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLICALLY ABNORMAL OBESITY; METABOLICALLY HEALTHY OBESITY; MOLECULAR WEIGHT; OBESITY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN FUNCTION; ADIPOSE TISSUE; AGE; ENERGY METABOLISM; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; INSULIN RESISTANCE; METABOLICALLY BENIGN OBESITY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; SEXUAL CHARACTERISTICS; YOUNG ADULT;

ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; ADULT; AGE FACTORS; ALLELES; ENERGY METABOLISM; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLUCOSE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; OBESITY, METABOLICALLY BENIGN; PHENOTYPE; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84969592387     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2016.05.003     Document Type: Article

References (44)

1. Friedman, J.M., A war on obesity, not the obese. Science 299 (2003), 856–858.
2. Field, A.E., Coakley, E.H., Must, A., Spadano, J.L., Laird, N., Dietz, W.H., et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161 (2001), 1581–1586.
3. Primeau, V., Coderre, L., Karelis, A.D., Brochu, M., Lavoie, M.E., Messier, V., et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes 35 (2011), 971–981.
4. Wozniak, S.E., Gee, L.L., Wachtel, M.S., Frezza, E.E., Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 54 (2009), 1847–1856.
5. Yang, W.S., Chen, M.H., Lee, W.J., Lee, K.C., Chao, C.L., Huang, K.C., et al. Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women. Int J Obes Relat Metab Disord 27 (2003), 896–900.
6. Maury, E., Brichard, S.M., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 314 (2010), 1–16.
7. Yang, W.S., Lee, W.J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.L., et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 10 (2002), 1104–1110.
8. Balistreri, C.R., Caruso, C., Candore, G., The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm, 2010, 2010, 802078.
9. Huang, K.C., Chen, C.L., Chuang, L.M., Ho, S.R., Tai, T.Y., Yang, W.S., Plasma adiponectin levels and blood pressures in nondiabetic adolescent females. J Clin Endocrinol Metab 88 (2003), 4130–4134.
10. Huang, K.C., Lue, B.H., Yen, R.F., Shen, C.G., Ho, S.R., Tai, T.Y., et al. Plasma adiponectin levels and metabolic factors in nondiabetic adolescents. Obes Res 12 (2004), 119–124.
11. Aguilar-Salinas, C.A., Garcia, E.G., Robles, L., Riano, D., Ruiz-Gomez, D.G., Garcia-Ulloa, A.C., et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93 (2008), 4075–4079.
12. Zhou, D., Jin, Y., Yao, F., Duan, Z., Wang, Q., Liu, J., Association between the adiponectin +45T>G genotype and risk of cardiovascular disease: a meta-analysis. Heart Lung Circ 23 (2014), 159–165.
13. Tsai, Y.S., Maeda, N., PPARgamma: a critical determinant of body fat distribution in humans and mice. Trends Cardiovasc Med 15 (2005), 81–85.
14. Yen, C.J., Beamer, B.A., Negri, C., Silver, K., Brown, K.A., Yarnall, D.P., et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241 (1997), 270–274.
15. Yang, W.S., Hsiung, C.A., Ho, L.T., Chen, Y.T., He, C.T., Curb, J.D., et al. Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia 46 (2003), 977–983.
16. Hulsmans, M., Geeraert, B., Arnould, T., Tsatsanis, C., Holvoet, P., PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression. PLOS ONE, 8, 2013, e62253.
17. Yang, W.S., Jeng, C.Y., Wu, T.J., Tanaka, S., Funahashi, T., Matsuzawa, Y., et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25 (2002), 376–380.
18. Pita, J., Panadero, A., Soriano-Guillen, L., Rodriguez, E., Rovira, A., The insulin sensitizing effects of PPAR-gamma agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats. Regul Pept 174 (2012), 18–25.
19. Yang, W.S., Yang, Y.C., Chen, C.L., Wu, I.L., Lu, J.Y., Lu, F.H., et al. Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr 86 (2007), 509–513.
20. Guzman-Ornelas, M.O., Chavarria-Avila, E., Munoz-Valle, J.F., Armas-Ramos, L.E., Castro-Albarran, J., Aguilar Aldrete, M.E., et al. Association of ADIPOQ +45T>G polymorphism with body fat mass and blood levels of soluble adiponectin and inflammation markers in a Mexican-Mestizo population. Diabetes Metab Syndr Obes 5 (2012), 369–378.
21. Cao, D., Ouyang, S., Liu, Z., Ma, F., Wu, J., Association of the ADIPOQ T45G polymorphism with insulin resistance and blood glucose: a meta-analysis. Endocr J 18 (2014), 437–446.
22. Bik, W., Ostrowski, J., Baranowska-Bik, A., Wolinska-Witort, E., Bialkowska, M., Martynska, L., et al. Adipokines and genetic factors in overweight or obese but metabolically healthy Polish women. Neuro Endocrinol Lett 31 (2010), 497–506.
23. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894 (2000), 1–253 i-xii.
24. Brochu, M., Tchernof, A., Dionne, I.J., Sites, C.K., Eltabbakh, G.H., Sims, E.A., et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women. J Clin Endocrinol Metab 86 (2001), 1020–1025.
25. Schoeller, D.A., Heymsfield, S.B., Lohman, T.G., Wang, Z.M., Going, S.B., (eds.) Hydrometry, 2005, 35–49 Champaign, IL.
26. Kuk, J.L., Ardern, C.I., Are metabolically normal but obese individuals at lower risk for all-cause mortality. Diabetes Care 32 (2009), 2297–2299.
27. Alberti, K.G., Zimmet, P., Shaw, J., I.D.F.E.T.F.C. Group. The metabolic syndrome – a new worldwide definition. Lancet 366 (2005), 1059–1062.
28. Waki, H., Yamauchi, T., Kamon, J., Ito, Y., Uchida, S., Kita, S., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278 (2003), 40352–40363.
29. Deurenberg-Yap, M., Deurenberg, P., Validity of deuterium oxide dilution for the measurement of body fat among Singaporeans. Food Nutr Bull 23 (2002), 34–37.
30. Bhat, D.S., Yajnik, C.S., Sayyad, M.G., Raut, K.N., Lubree, H.G., Rege, S.S., et al. Body fat measurement in Indian men: comparison of three methods based on a two-compartment model. Int J Obes 29 (2005), 842–848.
31. Gray, B., Steyn, F., Davies, P.S., Vitetta, L., Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. Eur J Clin Nutr 67 (2013), 1234–1242.
32. Jung, C.H., Kim, M.S., Molecular mechanisms of central leptin resistance in obesity. Arch Pharm Res 36 (2013), 201–207.
33. Das, P., Bhattacharjee, D., Bandyopadhyay, S.K., Bhattacharya, G., Singh, R., Association of obesity and leptin with insulin resistance in type 2 diabetes mellitus in Indian population. Indian J Physiol Pharmacol 57 (2013), 45–50.
34. Matsushita, K., Yatsuya, H., Tamakoshi, K., Wada, K., Otsuka, R., Takefuji, S., et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 26 (2006), 871–876.
35. Lu, J.Y., Huang, K.C., Chang, L.C., Huang, Y.S., Chi, Y.C., Su, T.C., et al. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci 15 (2008), 565–576.
36. Yang, W.S., Lee, W.J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.L., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001), 3815–3819.
37. Li, X., Wei, D., He, H., Zhang, J., Wang, C., Ma, M., et al. Association of the adiponectin gene (ADIPOQ) +45 T>G polymorphism with the metabolic syndrome among Han Chinese in Sichuan province of China. Asia Pac J Clin Nutr 21 (2012), 296–301.
38. Yang, W.S., Chuang, L.M., Human genetics of adiponectin in the metabolic syndrome. J Mol Med (Berl) 84 (2006), 112–121.
39. Jochmanova, I., Habalova, V., Wagnerova, H., Galovicova, A., Lazurova, I., T45G and G276 T adiponectin gene polymorphisms in primary aldosteronism and healthy controls in an East Slovak population. Physiol Res 62 (2013), 413–420.
40. Yang, W.S., Tsou, P.L., Lee, W.J., Tseng, D.L., Chen, C.L., Peng, C.C., et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med (Berl) 81 (2003), 428–434.
41. Lara-Castro, C., Fu, Y., Chung, B.H., Garvey, W.T., Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 18 (2007), 263–270.
42. Chang, L.C., Huang, K.C., Wu, Y.W., Kao, H.L., Chen, C.L., Lai, L.P., et al. The clinical implications of blood adiponectin in cardiometabolic disorders. J Formos Med Assoc 108 (2009), 353–366.
43. Xie, Y.J., Stewart, S.M., Lam, T.H., Viswanath, K., Chan, S.S., Television viewing time in Hong Kong adult population: associations with body mass index and obesity. PLOS ONE, 9, 2014, e85440.
44. Doo, M., Won, S., Kim, Y., Association between the APOB rs1469513 polymorphism and obesity is modified by dietary fat intake in Koreans. Nutrition 31 (2015), 653–658.